<DOC>
	<DOCNO>NCT01266772</DOCNO>
	<brief_summary>This 9 month , placebo-controlled , double blind , randomise trial use oral leucotrienes receptor antagonist montelukast ( 5 mg ) 160 child mild moderate asthma age 6-14 year old , sensitive house dust mite . There two study group : montelukast group 80 patient placebo group 80 patient . All patient receive budesonide dose sufficient control asthma symptom short-acting beta agonist need . Medication use study : montelukast 5mg , budesonide . There 7 doctor 's visit - one initial visit ( June ) 6 follow-up visit . First visit first day asthma symptom follow-up visit every 6 week . Children full asthma control ( measure exhale NO ) administer 100 mcg low dose budesonide child fully control asthma administer 100 mcg high dose budesonide .</brief_summary>
	<brief_title>Effect Montelukast Asthma Children</brief_title>
	<detailed_description>The potent anti-inflammatory drug asthma glucocorticosteroids . Corticosteroids , however side effect fully suppress production release inflammatory mediator . Amongst less affected cysteinyl leucotrienes , know play key role asthma . Antileucotrienes bronchodilator bronchoprotective potential thus become part current treatment recommendation asthma . Owing beneficial effect antileucotrienes effort keep steroid dos low , study address extent inhale corticosteroid might substitute supplemented drug . We use symptom , frequency exacerbation , exercise induce bronchoconstriction test , exhale NO stepwise reduction steroid dose assess association variable relation patient ' clinical benefit ; use airway hyperresponsiveness assess inflammatory process airway . This 9 month , placebo-controlled , double blind , randomise trial use oral leucotrienes receptor antagonist montelukast ( 5 mg ) 160 child mild moderate asthma age 6-14 year old , sensitive house dust mite . There two study group : montelukast group 80 patient placebo group 80 patient . All patient receive budesonide dose sufficient control asthma symptom short-acting beta agonist need . Medication use study : montelukast 5mg , budesonide . There 7 doctor 's visit - one initial visit ( June ) 6 follow-up visit . First visit first day asthma symptom follow-up visit every 6 week . Children full asthma control ( measure exhale NO ) administer 100 mcg low dose budesonide child fully control asthma administer 100 mcg high dose budesonide . Methods use study : - doctor 's exam - asthma symptom questionaire - exhale NO - spirometry - exercise induced bronchoconstriction test - airway hyperresponsiveness test End point : - steroid dose sufficient control asthma symptom - medium steroid dose/day time 6 month - number asthma exacerbation 9 month period - maximum fall FEV1 exercise induce bronchoconstriction test - asthma symptom scale lung function - number patient positive airway hyperresponsiveness test</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Children bronchial asthma All serious disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>asthma ; child ; montelukast ; treatment ; exacerbation</keyword>
</DOC>